doxorubicin loaded eosomes (EOS Biosciences)

N/A

Report date: 2025/01/26 16:42:09

Base Information

Drug Namedoxorubicin loaded eosomes (EOS Biosciences)

Drug Alias NameEos-001doxorubicin

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionTopoisomerase II inhibitorsReceptor tyrosine-protein kinase erbB-3 modulatorsVirus DNA polymerase inhibitors

TargetsTopoisomerase IIReceptor tyrosine-protein kinase erbB-3Virus DNA polymerase

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEOS BioSciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A